Acumen Pharmaceuticals announced Derrell Porter, M.D., has joined its Board of Directors. Dr. Porter is a physician-entrepreneur with more than 20 years of experience in drug development. He is currently the Founder and CEO of Cellevolve, a development and commercialization cell therapy biotech focused on neglected diseases.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABOS:
- Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
- Acumen reports Q3 EPS (26c), consensus (23c)
- Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
- Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
- Acumen Pharmaceuticals to Report Third Quarter 2022 Financial Results on Nov. 14, 2022